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Background: Academic performance enhancement or cognitive enhancement (CE) via stimulant drug use has
received increasing attention. The question remains, however, whether CE solely represents the use of drugs for
achieving better academic or workplace results or whether CE also serves various other purposes. The aim of this
study was to put the phenomenon of pharmacological academic performance enhancement via prescription and
illicit (psycho-) stimulant use (Amphetamines, Methylphenidate) among university students into a broader context.
Specifically, we wanted to further understand students’ experiences, the effects of use on students and other
factors, such as pressure to perform in their academic and private lives.
Methods: A sample of 18 healthy university students reporting the non-medical use of prescription and illicit
stimulants for academic performance enhancement was interviewed in a face-to-face setting. The leading questions
were related to the situations and context in which the students considered the non-medical use of stimulants.
Results: Based on the resultant transcript, two independent raters identified six categories relating to the life
context of stimulant use for academic performance enhancement: Context of stimulant use beyond academic
performance enhancement, Subjective experience of enhancement, Timing of consumption, Objective academic
results, Side effects, Pressure to perform.
Conclusions: The answers reveal that academic performance enhancement through the use of stimulants is not an
isolated phenomenon that solely aims at enhancing cognition to achieve better academic results but that the
multifaceted life context in which it is embedded is of crucial relevance. The participants not only considered the
stimulants advantageous for enhancing academic performance, but also for leading an active life with a suitable
balance between studying and time off. The most common reasons given for stimulant use were to maximize time,
to increase motivation and to cope with memorizing. According to the interviews, there is a considerable
discrepancy between subjective experiences and objective academic results achieved.
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University studentsBackground
The non-medical use of so-called “smart drugs” among
students with the aim of increasing mental performance
has attracted considerable media attention over the
past few years [1]. In particular, prescription stimulants
(methylphenidate, prescription amphetamines e.g. Adderall®),* Correspondence: hildt@uni-mainz.de
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reproduction in any medium, provided the orother prescription drugs (modafinil, antidementives),
as well as illicit drugs (e.g. illicit AMPH, cocaine) have
been used in this context [2-4].
Regarding the effects of these “smart drugs”, there is very
limited scientific evidence to support the pro-cognitive
properties in healthy individuals. Current research data
from randomized double-blind placebo-controlled trials
(RCTs) among healthy subjects show inconsistent (pro-)
cognitive effects on solely simple and higher cognitive do-
mains with stronger pro-cognitive effects on sleep-deprivedd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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recent study revealed the lack of enhancing effects of mixed
amphetamine salts on cognitive abilities in healthy young
individuals [8]. In spite of this, in anecdotal reports and
quantitative and qualitative studies users said to subjectively
experience positive effects on cognition [8-10]. In addition,
growing evidence indicates that healthy users perceive
motivational and emotional effects to be of value in the
non-medical use of psychostimulants [11,12].
In the non-medical use of psychostimulants, safety
risks and side effects of stimulants (e.g. gastrointestinal
symptoms, dizziness, induction of psychosis or mania)
as well as misuse, a certain abuse potential and withdrawal
symptoms have to be considered [5,13,14]. Beyond that,
the distinctions between the use of prescription stimulants
and illicit stimulants concerning safety risks, methods
of acquisition, legal consequences and costs have to be
regarded. In this respect the legal and health risks of
the use of illicit stimulants seem to be much higher
than of the use of prescription stimulants.
The use of “smart drugs” has been described using
various terms including “pharmacological cognitive
enhancement” (CE), “(pharmacological) neuroenhancement”,
“cosmetic neurology” or “brain doping” [1,4,15]. These
terms are usually used to refer to attempts to enhance
cognitive functions such as attention, memory or other
cognitive domains that are of particular interest for
academic performance [16].
Up to now, however, most studies on mental enhance-
ment purposes predominantly focus on the general misuse
of prescription and illicit stimulants. In addition to en-
hancement purposes, these studies also tend to describe
other contexts of stimulant misuse, associated with pur-
poses like recreational use, getting high, experimenting,
partying, boosting creativity [17,18]. Most recent epi-
demiological studies of substance use among students
increasingly focus on the aspect of “academic perform-
ance enhancement” [19-23]. However, the extent to
which academic performance enhancement can be sepa-
rated from partying, getting high and the other above-
mentioned purposes remains unclear.
Previous studies revealed a huge range of prevalence
rates, results depending on the survey method, type of
substance used for CE and surveyed subjects. According to
these, the primary purpose and context of the use of drugs
(to get high, to increase concentration, recreational use, etc.)
seem to be the most important factors amongst the
huge range of prevalence rates. Taken together, current
research indicates a prevalence rate for these sub-
stances for CE of at least 3 – 20% among university
students [19-22]. Assuming academic performance en-
hancement to be a stigmatizing subject, the two most
recent studies – which promised a high anonymity to
participants – revealed a lifetime prevalence rate of 20%for prescription stimulants (web-based) and a 20% last-year
prevalence rate (Randomized Response Technique) for the
“use of drugs that you can only buy in a pharmacy for
academic performance enhancement” [20,24].
The prevalent use of potential cognitive enhancing
drugs on high school and university campuses seems sur-
prising in light of the very limited pro-cognitive effects
and sizeable side effects described in literature and given
the illegality of misusing prescription and illicit drugs. Sev-
eral reasons can be assumed for the current interest in so-
called pharmacological cognition enhancers in academic
contexts [11]. One reason may be recent media hype on
the putative cognition-enhancing effects of psychostimu-
lants which may have resulted in the assumption among
students that psychostimulants serve to increase academic
performance [1,25]. Another reason may be that there
is a benefit for at least part of the users, but that up to
now this benefit is not adequately reflected in litera-
ture. It is also possible that for genetic or other rea-
sons, part of the healthy population is particularly
susceptible to cognition-enhancing effects of psychos-
timulants. Alternatively, there may be a non-cognitive
effect of psychostimulant intake that students consider
of value in academic contexts [11,12].
In order to find out more about the latter possible
explanation and about the real life context of drug use for
academic performance enhancement, we ran the present
study. In this, leading questions are: Why do students
(and other persons) use stimulants in academic contexts?
What are the effects users experience and consider of
value? Does the use of stimulants in academic contexts
provide advantages? How does it impact the students’
lives? What are the side-effects experienced?
Up to now, there is a considerable lack of qualitative
research that might be able to answer questions like these.
Remarkable exceptions are two studies by DeSantis and
colleagues [26,27], Partridge and colleagues [28] as well as
the recent interview study by Scott Vrecko, which focuses
on the users’ experiences of non-medical stimulant drug
use [12]. A recent quantitative study by Ilieva and Farah
provides support to the hypothesis that there may be
non-cognitive effects of psychostimulant intake that are
considered as advantages by healthy individuals [11]. In
contrast, the existing epidemiological studies are not
able to give explanations for the prevalent phenomenon
of academic performance enhancement and can only
speculate about deeper reasons and motivational factors.
Furthermore, they do not reveal anything about the
“every-day” and “real world” effects of stimulant use
among students. Currently, in particular the last aspect
is a research desideratum.
The present study aims to reduce this lack of empirical
scientific data about contextual factors and real world ef-
fects of academic performance enhancement. In order to
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enced effects of stimulants and their impact on academic
results and the user’s life in- and outside university, we con-
ducted semi-structured interviews on a group of university




We posted placards on public bulletin boards throughout
the University of Mainz campus asking students who
had used prescription or illicit (psycho-) stimulants
(amphetamines =AMPH, methylphenidate =MPH, ecstasy,
cocaine) for CE purposes to contact us anonymously
via email. Placards promised an expense allowance of
30,- Euros for participation. Only healthy students without
psychiatric disorders (e.g. attention-deficit hyperactivity
disorder (ADHD), schizophrenia) and current physicians’
prescriptions of psychoactive medication (e.g. Ritalin®) were
included in the study. 22 interviews were carried out.
Interview guideline
An extensive semi-structured face-to-face interview guide-
line was developed. After gathering socio-demographic
information (age, sex, study subject, grades, etc.) we asked
questions concerning the intake of prescription and illicit
stimulants with the particular intention of academic per-
formance enhancement and factors associated with this
use. Of particular interest here are questions relating
to the background of (psycho-) stimulant use, such as
“Why did you take the stimulant?”, “Did you experience a
considerable increase in mental performance?”, “Did
your academic results actually improve as a direct result
of taking the stimulant drug?”, “Did you experience
negative side effects?”.
Procedure
A psychologist and three interviewers were trained for
the interview procedure. The psychologist examined all
participants to ensure that all candidates with psychiatric
diseases and current physicians’ prescriptions of psycho-
active medication were excluded. Subsequently, each
participant was interviewed by two people at a time. The
interviews were tape-recorded. To avoid loss of information
(e.g. acoustic problems of sound recording), one interviewer
asked the questions whilst the other noted down answers
to closed questions and catchwords to open questions to
complement the tape-recording.
Participants gave written informed consent for being
interviewed and for the tape-recording of the entire inter-
view. They received an expense allowance of 30,- Euros
when the interview was over. The study was approved by
the local Ethics Committee of the Landesärztekammer
Rheinland-Pfalz (Medical Association Rheinland-Pfalz).Analysis
Records were transcribed verbatim by a person who was
not involved in the interview procedure. The anonymous
transcriptions were then analyzed systematically using a
qualitative approach based on inductive category develop-
ment [29-31]: Two independent raters (Hildt and Franke)
analyzed the transcriptions blindly. The answers given
by the participants relating to the impact of the use of
prescription and illicit stimulants on individual life context
in- and outside university were analyzed and categories
subsequently formed. To ensure objective analysis, only
those categories upon which both raters agreed were used
for the final analysis for this paper.
Based on this method, some preliminary results concern-
ing users’ views on the (moral) differences between caffeine
and illicit/prescription stimulants for CE [9] and concerning
information transfer [32] have already been published.
Results
Participant characteristics have already been described in
Franke and colleagues (2012) concerning users’ views about
(moral) differences between caffeine and prescription/illicit
drugs [9]. To summarize, only some (n = 30) students con-
tacted us via telephone or e-mail. Having corresponded
with these candidates to identify potential exclusion criteria
and following a further planning procedure, 22 interviews
were carried out. 4 interviews were not analyzed because
of diagnosed ADHD, Pseudologia fantastica or technical
reasons. 18 interviews entered further analysis.
Among all participants (n = 18 = 100%), 77.8% (n = 14)
had used illicit stimulants (AMPH) and 38.9% (n = 8)
prescription stimulants (MPH). 22.2% (n = 4) had used
prescription as well as illicit stimulants for academic
performance enhancement.
Participants were 25.8 ± 2.88 years old (mean). 66.7%
(n = 12) of all participants were male, 33.3% (n = 6) female.
Participants had already completed 7.35 ± 3.79 semesters
(mean) and were attached to three different departments
(Humanities: 44.4%, n = 8; Natural Sciences: 33.3%, n = 6;
Economics: 22.2%, n = 4).
The average age of first stimulant use for CE was
20.4 ± 2.88 years. Frequency of stimulant use for academic
performance enhancement varied widely from nonrecur-
ring use up to daily use during specific periods of time, e.g.
during exam preparation.
Based on the selected answers concerning the impact
of stimulant use on the students’ personal life, categories
were formed independently by two raters. Rater 1 created
9 categories and rater 2 created 8 categories. The raters
agreed on 6 categories. Categories with congruent con-
tents that were formed by both raters were used for fur-
ther analysis (Figure 1). Here we partly reproduce direct
speech as stated by the interviewees to give a lively insight
into the embedded context of CE.
Figure 1 Procedure of building categories for analysis.
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academic performance enhancement
Several students did not limit their use of stimulants
(AMPH) to academic ends, but also resorted to them for
other purposes, such as composing music or for a band
performance. This indicates that they also used stimulants
for non-academic purposes. Some of them said they pri-
marily used illicit AMPH during leisure time and only
rarely in order to improve mental performance for aca-
demic purposes (“I took it three or four times as a perform-
ance enhancer, but even more often just in my free time.”).
Other participants reported that stimulant use helped
them to better pursue the projects they value outside of
university so that they had time and energy left for leis-
ure activities (“Usually I have more in my head than I
have time for. So when I wanted to do other things apart
from studying, I took it, too.”). A participant said that
it enabled him to begin a career in music and to con-
tinue studying at university at the same time. Another
student reported that AMPH stimulants served to prolongcomputer game sessions. Another participant claimed to
use AMPH in order to brighten up trivial activities, such as
cleaning his flat. One student took MPH to fight fatigue
during a night of waiting at the airport.
Several of the students who used illicit AMPH said
they first took it for recreational purposes or partying
and only later came to know that it might be useful for
academic purposes (“Primarily I started taking it as a
party drug. I didn’t become aware of the positive effect
in other parts (like studying) until later”).
Category 2: timing of consumption
In academic contexts, most of the students interviewed
used stimulants for studying and exam preparation. Some
used them in order to write a term paper or to prepare a
presentation. Several of them said it allowed them to study
for longer periods of time without breaks and to be less
prone to boredom (“The other students who didn’t take it
(MPH) were able to study for about 3 to 4 hours during
the exam phase and afterwards they were shattered and
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library and I studied all the way through with hardly
any breaks.”).
For others, the main benefit was to gain time or com-
pensate for lost time. These students might take the
drug if they left too little time to prepare for an exam
(“I thought: ‘Oh no, only 3 days to go till the exam, I
don’t know a thing and I need to know it all by heart.
What should I do?’ And then I took Ritalin for three
days and hardly slept.”).
Some students took stimulants just on the night before
the exam in order to prepare for the test. According to
them, AMPH is particularly suitable in this respect insofar
as it reduces the sleep requirement (“Sometimes when I
knew: ‘Alright tomorrow there’s a test and I haven’t done
anything again’. Then I took it in the evening and I went
to school in the morning without any sleep having spent
the night studying.”; “The problem is, if you study the
night before, then you have to take amphetamines again
the next morning.”).
A considerable number of students used stimulants,
particularly prescription stimulants, during exams.
However, some students viewed the side effects of (illicit)
AMPH as problematic during exams or in situations with
some kind of “external control” (“I tend to sweat more and
talk faster and I have a faster flow of words. And in my
opinion, this is conspicuous.”). Nevertheless, some students
were on AMPH during exams.
Whereas most participants used CE predominantly
during exam periods, i.e. for 2-3 weeks or sometimes
longer, a few of the students took the drugs for longer
periods of time: one student because he felt permanently
under time pressure, and another reported to have taken
(illicit) AMPH regularly for an extended time period in
the past as a consequence of its addictive effects.
Category 3: subjective experience of enhancement
We received multifaceted responses to the question
inquiring to what extent the students experienced an
actual increase in performance as a result of drug use.
A considerable number of students reported an increase
in concentration and receptiveness and in their ability
to focus on the learning material. The used stimulant
was considered particularly to be helpful in situations in
which the brain is required to record large amounts of
information. A typical answer is: “I could focus better
and I wasn’t as distracted.”
Some participants described an increase in their mo-
tivation to revise (“…normally, when I have to study
for long I get bored. (…) That’s the difference I noticed
when I started taking Adderall. I didn’t really want to
stop…”). Others stressed the ability to achieve more in
a limited space of time as the principal reason for using
stimulants (“What you could see as an effect is that Ifinished quicker which saved me time. I don’t think I
got better, though.”).
A student participant emphasized that he experienced
an improvement in memory functions (“Usually I have
to get things into my short-term memory and then into
my long-term memory, basically just reading through a
couple of times. Under Ritalin it was enough to read over
it quickly and I was able to remember it days afterwards
without Ritalin. Well, as I said, the things that I study with
Ritalin stay there longer.”).
Another participant reported a positive effect with regard
to learning simple content (e.g. vocabulary); however,
the beneficial effects were less pronounced when it came
to more complex material and negative effects were men-
tioned when attempting to learn and understand complex
material (“If you have to understand the link between
everything, it (AMPH) wasn’t a big help at all. So AMPH
is good for everything that you just have to learn by heart.
AMPH was good in that moment. But when it gets more
complicated then AMPH is just obstructive.”).
Others described the effects of (illicit) AMPH as even
more ambivalent. A student said: “Reading a text with
AMPH is quite nice, you’re just concentrated and awake,
but your attention isn’t that much better and because of
that your memory is not working that well either. What
was that on the other page? It’s there but not well con-
nected. It’s like a virtual picture in your head, you can
access it but it’s not connected at all.” One participant
reported of lack of concentration and inability to focus
on a defined task under illicit amphetamines.
Beyond that, users of (illicit) AMPH also considered
other effects to be of relevance in their stimulant use.
For some students, an important aspect of AMPH intake
is that less sleep is required which leads to an acquisition of
time. For instance, AMPH enabled them to learn during
the night before their exam (“The advantage is the oppor-
tunity to be awake and concentrated which doesn’t really
make studying better though. It’s just gaining time.”). Other
participants value an increase in creativity (“You have loads
of ideas that you never had before.”) Some participants
also suggested that AMPH improved communication:
“[In the German written exam] I took it because I felt
that the flow of words and what you say increases, so
writing down what you’re trying to put into words gets
easier and even more creative”.
Category 4: objective academic results
A crucial question with regard to the relevance of CE in
academic performance is whether participants’ results
actually improved. The answers obtained were inconsistent:
although most students considered the use of stimulants to
have had some positive influence, only few participants
were confident that the drug had a direct positive impact
on their grades. Others said that they did not achieve better
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the drug helped improve their grades. A typical answer re-
garding AMPH use for academic performance enhance-
ment was: “It was only the feeling I had. There wasn’t really
a difference between the results with or without taking it.”
Nevertheless, many of them appreciated some other
effect connected to the use of stimulants: that stimulant
use increased their motivation, helped them meet deadlines
(e.g. for term papers), or increased their learning cap-
acity and effectiveness of learning (“I think I could have
gotten the good results also without Ritalin. But because
I always leave the things that I don’t like till last minute,
I can say that it did help me. But maybe I couldn’t be
bothered to study without taking it.”; “For me it’s just a
motivation thing.”).
Another student reflected on the correlation between
effort and results (“You’re able to study more in less
time because of an increased attention. So if I’d spend
more time for studying the results would have been the
same as with the stuff [AMPH]. When I consider the time
and the effort, then the result was better, yes.”).
In the students’ reflections on whether or not the stimu-
lant drugs had beneficial effects, the distinction between
the subjective impression of experiencing some kind of in-
crease in mental performance and the objective effects at-
tached to the drug use played a considerable role. It raises
the question as to whether the supposed positive effect is
simply a subjective feeling or whether it actually has an en-
hancing effect (“In that moment I felt as if it was better. But
the results weren’t as good as I expected, especially with
amphetamines”; “At the time, [when under the influence by
AMPH] you feel as if you understand it quicker, maybe that
it’s of considerable use. But afterwards, when you have an-
other look, maybe study again afterwards or talk about it
with somebody then it shows that it was more obstructive
than beneficial, at least in my experience.”).
Category 5: side effects
The students experienced considerable side effects in-
cluding tachycardia, sleeplessness, restlessness and tremor.
Several participants said that in spite of the side effects ex-
perienced, they went on taking the stimulant because they
appreciated its positive effects.
Side effects observed depended on the duration of
intake. With regard to illicit AMPH, a participant said:
“After a day [of AMPH use] everything is fine, but after
two days it gets worse and on the third day you’re just
shattered.”; “It depends on the duration of the intake
(AMPH). You do get kind of tired because it is consump-
tive, so I can’t take it more than once or twice a month. I
used to take it every day and it was really crappy because I
was completely exhausted.”
Some students claimed to have been struck by depressive
moods as a result of MPH use (“It’s some sort of stimulant,you feel high and then it’s like a rollercoaster. Like the
rollercoaster going up and then down again. It’s sort of
like that. This depressive mood [after the use of stimulant
drugs], it’s really not worth it. To me it’s a very unpleasant
feeling.”). One of them reported on more long-term de-
pressive feelings from MPH use. He said that he managed
to suppress the depressive mood by taking another MPH
tablet the following day. In addition, he reported a consid-
erable influence of the psychostimulant on his social life
(“I completely separated myself from the outside world
while I took Ritalin. In light of this I don’t know whether
my depressive mood was because of Ritalin. Or maybe it
was just that I hardly had any more contact with friends
and that I didn’t go out at a night anymore. Instead I spent
the whole day at the university.”).
After a prolonged period of illicit AMPH abuse, a partici-
pant reported having developed addictive behaviour.
Category 6: pressure to perform
Several participants explicitly mentioned pressure to per-
form as the main reason for stimulant use. One person
talked about compensating pressure to perform by using
stimulants for recreational purposes in this way: “I also
take it to balance the work-related stress and the pres-
sure to perform.” Another participant talked about
pressure to perform in academic contexts and about
the perceived need to adapt to the educational system
and its needs as follows: “The thought of there being
so much to do for school and of turning into some sort
of a machine really wore me down.” Another student
said, “[…] I want to be better than my peer group and
fellow students, although I realize that that sounds ra-
ther anti-social. But when it comes to group work, it
really gets to me when my fellow students contribute
so little. […] Personally, I care about getting good
marks, particularly in my bachelor thesis, and ending
up with a well-paid job. Although it is perhaps selfish, I
think it’s o.k. [to use CE substances].”
Discussion
All students interviewed used prescription stimulants, in
particular MPH (Ritalin®) or illicit AMPH, for academic
performance enhancement. However, there were also
other purposes (recreational use, partying, etc.). This is in
accordance with a meta-analysis by Wilens and colleagues
[18]. This broad spectrum of uses partly explains why, to
date, empirical knowledge concerning prevalence rates
relating to pure academic enhancement is scarce. In
addition, the data reveal that, in particular, those who
used illicit AMPH in the beginning often did so in the con-
text of partying and only later switched to (also) using the
substances for academic performance enhancement. This
suggests that stimulant use may spread from recreational
use and partying to academic contexts.
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not so much to improve academic results but to achieve
an adequate work-life-balance and to have time and energy
left for leisure activities. According to the results obtained,
some users consumed stimulants in order to pursue their
individual projects outside the academic sphere. This aspect
sheds new light on CE, which is often perceived solely as a
strategy to exceed natural cognitive capacity in competitive
situations at school, university or in the workplace. Instead,
if one takes the users’ overall life situation into consid-
eration, it seems that they perceive stimulants at least
partly as beneficial for leading an “active life” without
being focused too much on academics. The results ob-
tained here are well in line with a recent publication by
Partridge and colleagues, who tentatively suggest that
one motivation for stimulant use among students may
be to maintain an active social life [28].
When stimulants were used for academic purposes, the
main reasons listed were to facilitate exam preparation, to
gain study time and to help prepare a term paper. Time
pressure and pressure to perform are of considerable rele-
vance here. Stimulants were also taken on exam days to
improve performance. From this it is plausible to assume
that during exam periods or during other periods of high
academic stress, stimulant use among university students
increases, this assumption coincides with recent results
obtained by wastewater analysis of amphetamine and rita-
linic acid at a US college campus [33].
Interestingly, when asked whether stimulant intake
was helpful for obtaining better academic results, the
participants gave rather ambivalent answers. Accord-
ing to the interviewees, it is not clear whether stimu-
lant intake had objective positive effects on academic
performance or, contrarily, whether it was of no help at
all or even obstructive.
This inspires the question: What are the benefits of
psychostimulant use? To what extent does it increase
the mental performance or cognitive abilities of healthy
individuals?
The answers we received indicate that the benefits
experienced do not include improved cognitive abilities
such as planning or complex information processing but
rather help with learning by heart. The results seem to
imply that psychostimulant intake has a positive motiv-
ational effect which fosters concentration, receptiveness
and ability to focus. This effect has been confirmed by
previous studies [4,12]. Furthermore, several students
appreciated other beneficial effects such as a reduced
need for sleep, increased motivation or the feeling of
being “re-energized”. Several students involved in the
music scene cited increased creativity as a reason for
AMPH use. When we compare these interview results
with scientific literature on cognitive enhancers, it
seems that users most appreciate the wake-promotingand pro-vigilant effects described in previous studies.
According to current scientific data, although wake-
promoting substances may promote alertness and con-
centration at night for learning purposes, they enhance
neither memory, nor other higher cognitive domains,
nor mood. Furthermore, these very mild pro-cognitive
effects have proved more effective in sleep-deprived
subjects compared to normal healthy subjects [4].
As underlined by the users’ answers, it is not so much
the hope of improving higher cognitive functions which
stimulates them to take drugs for academic performance
enhancement but, rather, the wake-promoting and mo-
tivational effects associated with them.
Taken together, among the main motivations for
non-medical use of stimulants by students seem to be
the motivation to get things done, be it in order to
meet academic demands or to have a fulfilling leisure
time, and the motivation to feel active and energetic
while performing their tasks. This supports the findings
by Partridge and colleagues [28].
Thus, even if the stimulants currently used for enhance-
ment purposes are not very effective as cognitive enhancers,
i.e. fail to increase complex cognitive functions, they
nevertheless seem to be considered advantageous by a
certain group of students. It would therefore be inad-
equate to declare current so-called cognitive enhancers
to be useless based on the grounds that they do not ef-
fectively increase complex cognitive abilities. Instead,
the interviews revealed that the predominant reason why
students turn to these drugs today is their motivational
and wake-promoting effects.
The main motive explaining why some students use
psychostimulants for CE is the prospect of studying in a
more efficient and fulfilling way. In this context, maximiz-
ing time and boosting motivation are two of the most
important aspects. In addition, for the users, one of the
most attractive functions of stimulants such as MPH
or AMPH is the procurement of a good feeling during
exam preparation and exams. This helps them to cope with
stressful situations – an effect that could be explained by
euphoric effects of psychostimulants.
The results obtained here are in considerable accordance
with the study by Vrecko [12] who reported not so much
an influence of psychostimulants on cognition but on
emotional or affective states. In this qualitative study,
based on semi-structured interviews with 24 students
who used stimulants for CE, the author identified
emotion-related statements in the interviews which he
grouped into four categories: “Feeling Up”, “Drivenness”,
“Interestedness”, “Enjoyment”. Even if in the study here
we did not focus on emotional or affective states, there
obviously are several parallels, in particular with regard to
the relevance the interviewees conferred to the subjective
experience of psychostimulant use. Strikingly, both studies
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use is to be able to handle the demands of university, in
particular, with regard to the practical, motivational and
emotional aspects of studying and preparing for exams.
This is in perfect line with a recent study by Ilieva and
Farah [11] who found out that students who used psy-
chostimulants for enhancement perceived motivational
advantages of stimulant use to be at least as pronounced
as cognitive effects.
Interestingly, several participants believed that if they
had started earlier with exam preparation and taken
their studies more seriously, they would have had the
same academic results. Stimulants seem to be of particu-
lar value to those students who lack motivation or who
start preparing for exams at the last minute. However, it
is important to stress that there are surely other, non-
pharmacological means of achieving these ends. These
include reducing time pressure, working in a more disci-
plined way or improving the balance between university
and private life.
Although it is generally presumed in the academic de-
bate that those who avail themselves of so-called cogni-
tive enhancers benefit from drug use, only two of the
students interviewed were confident that with stimulant
use they achieved better academic results, i.e. better
grades. According to the interviews, students who took
stimulants (MPH/AMPH) rarely obtained better results
during exams. What students seemed to appreciate most
about the drug was the increased motivation to study
and the time they gained.
The results lead us to question a direct distorting effect
of psychostimulants on the grades obtained in university
exams, i.e. an effect that benefits the users. On the one
hand, at the moment, it seems that students who do
not take psychostimulants need not feel disadvantaged
or pressured to use enhancers themselves in order to
avoid being left behind. On the other hand, however, it
may be argued that there may be an indirect advantage
to those who use enhancers in terms of motivation or
higher learning effectiveness. Furthermore, psychosti-
mulants may confer a certain advantage with regard to
time pressure.
In addition, as can be inferred from several answers,
there is a difference between people saying that they
experienced a positive, enhancing effect from psychos-
timulant use and the objective, empirically detectable
existence of a significant enhancing effect. This concurs
with the idea that psychostimulant use is associated with
the overestimation of one’s own capabilities. The results
obtained here are in accordance with a recent quantitative
study on the effects of mixed amphetamine salts on
healthy young adults [8]. Overall, the study did not reveal
significant enhancement effects on cognitive performance
in a set of 13 measures of cognitive ability examined.Nevertheless, compared to those who received a placebo
pill, those who had taken a stimulant pill believed their
cognitive performance to be more enhanced. It is import-
ant to keep the distinction between objective effects and
subjective perception of effects in mind as it may help us
to avoid an over-optimistic picture of the purported posi-
tive, cognition-enhancing effects of stimulants.
The interviews suggest that side effects are considerable,
which is in contrast to the results obtained by deSantis
and Hane [26]. Side-effects are one important reason why,
in most cases, stimulants were not used for a long period
of time, but intermittently, interwoven with long periods
of abstinence. Several users mentioned sleep deprivation
and related consequences, and reported on the need to
adjust drug intake in order to avoid seriously disrupting
their sleep patterns. When stimulants were taken over
a longer period of time (weeks etc.), side effects became
aggravated. In particular, some students reported depres-
sive periods once the drug had lost its stimulating effects.
Furthermore, one participant stated a development of
addictive behaviour. Aspects related to addiction and the
users’ views on the risk of addiction will be discussed in
more detail in a separate manuscript.
It is important to note that this study is hampered by
several limitations. One of them is the limited number of
interviews: Only 18 interviews were taken into consider-
ation. In spite of the fact that the University of Mainz has
36.000 registered students who had the possibility to notice
the advertising placards of this interview study throughout
the campus, only 30 students contacted us, and only 22
were willing to participate. Given CE prevalence rates of
3 – 20%, there should have been a much higher number
of potential participants for this study. We hypothesize
that the stigmatizing subject of this study is the reason for
the low participation rate, notwithstanding the fact that
anonymity was guaranteed and that participants were
remunerated for their time and effort with 30,- Euros.
The “type” of student willing to participate may display
the main bias of the small group of participants. Partici-
pants had to be frequently enough at the campus, had to
have enough time for the interview study, had to be in-
terested in participating in scientific studies, had to be
convinced about the importance of the CE phenomenon,
had to take the risk to talk about their illegal behaviour
without being punished, etc. This kind of a “self-selection”
of participants may have led to a certain bias in the com-
position of the group of participants.
In addition, the exclusion of students with psychiatric
disorders and current physicians’ prescriptions of psy-
choactive medication leads to bias implying that the
present study is not representative for the entirety of
students. The prevalence rate of psychiatric disorders
among the population is high – e.g. 5.3% for ADHD
among children/adolescents, 4.4% among adults [34,35].
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important bias. However, it was not the aim of this study
to explore CE aspects among patients but among healthy
subjects. Including ADHD patients would have meant
to include participants with a totally different context
of stimulant use (misuse of own prescription medication)
and would have diluted the distinction between therapy of
disorders and enhancement of healthy people’s abilities.
It is questionable whether we excluded potential partici-
pants who faked or exaggerated ADHD symptoms for a
prescription of stimulants by a physician.
Furthermore, the interviewees gave us their spontaneous
answers to the questions we asked in the interviews. The
answers we obtained are in no way exhaustive or compre-
hensive, nor can we assume that the participants frankly
told us everything that came to their minds. Instead, the
answers represent an extract that may be influenced by
aspects such as present time frame, social desirability or
the participants’ perceived need to justify their behaviour.
Nevertheless, it is reasonable to assume that, overall, the
answers represent the actual views and experiences of the
interviewees since the interviews were held in a very re-
laxed atmosphere and the participants obviously did not
refrain from stating drawbacks and doubts concerning CE.
The data obtained in this preliminary qualitative study
is in no way representative. It is important to stress that
based on the interviews, we are not able to draw definite
conclusions on the effects of stimulant intake for en-
hancement purposes in healthy individuals in general.
The answers represent the purely subjective views of the
interviewees. Nevertheless, the reports are very valuable
because they give us insights on the factors which lead
students to use stimulants for academic performance
enhancement.
Conclusions
The results obtained reveal that academic performance
enhancement through the use of stimulants is not an
isolated phenomenon that solely aims at enhancing
cognition to achieve better academic results but that
the multifaceted life context in which it is embedded is
of crucial relevance. The participants not only considered
the stimulants advantageous for enhancing academic
performance, but also for leading an active life with a
suitable balance between studying and time off. The
most common reasons given for stimulant use were to
maximize time, to increase motivation and to cope with
memorizing. According to the interviews, there is a con-
siderable discrepancy between subjective experiences
and objective academic results achieved.
More research needs to be carried out to better under-
stand the practice and context of academic performance
enhancement. The results obtained here may serve as
a starting point for future qualitative and quantitativeresearch. It will be necessary to know more about the
students’ motivations for pharmacological neuroen-
hancement and about its objective effects on academic
performance achieved. In addition, research should be
done on drug use put in the context of other strategies
for coping with pressure to perform in academic contexts
which will include questions such as: What other ways are
there to cope with pressure that do not involve the misuse
of drugs? To what extent does society play a role in the
field of neuroenhancement? All of this will form the basis
for future policy recommendations concerning pharmaco-
logical neuroenhancement.
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